208 related articles for article (PubMed ID: 32106215)
1. Screening for Lung Cancer - 10 States, 2017.
Richards TB; Soman A; Thomas CC; VanFrank B; Henley SJ; Gallaway MS; Richardson LC
MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(8):201-206. PubMed ID: 32106215
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
[TBL] [Abstract][Full Text] [Related]
3. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
[TBL] [Abstract][Full Text] [Related]
4. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
; Krist AH; Davidson KW; Mangione CM; Barry MJ; Cabana M; Caughey AB; Davis EM; Donahue KE; Doubeni CA; Kubik M; Landefeld CS; Li L; Ogedegbe G; Owens DK; Pbert L; Silverstein M; Stevermer J; Tseng CW; Wong JB
JAMA; 2021 Mar; 325(10):962-970. PubMed ID: 33687470
[TBL] [Abstract][Full Text] [Related]
5. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
[TBL] [Abstract][Full Text] [Related]
6. Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.
Fucito LM; Czabafy S; Hendricks PS; Kotsen C; Richardson D; Toll BA;
Cancer; 2016 Apr; 122(8):1150-9. PubMed ID: 26916412
[TBL] [Abstract][Full Text] [Related]
7. Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.
Wu GX; Goldstein L; Kim JY; Raz DJ
Clin Lung Cancer; 2016 Sep; 17(5):e131-e139. PubMed ID: 26872765
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
Toumazis I; de Nijs K; Cao P; Bastani M; Munshi V; Ten Haaf K; Jeon J; Gazelle GS; Feuer EJ; de Koning HJ; Meza R; Kong CY; Han SS; Plevritis SK
JAMA Oncol; 2021 Dec; 7(12):1833-1842. PubMed ID: 34673885
[TBL] [Abstract][Full Text] [Related]
9. Lung Cancer Screening.
Hoffman RM; Sanchez R
Med Clin North Am; 2017 Jul; 101(4):769-785. PubMed ID: 28577626
[TBL] [Abstract][Full Text] [Related]
10. The United States Preventive Services Task Force recommendations for lung cancer screening.
Blackmon SH; Feinglass SR
Thorac Surg Clin; 2015 May; 25(2):199-203. PubMed ID: 25901563
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
[TBL] [Abstract][Full Text] [Related]
14. 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.
Luo YH; Luo L; Wampfler JA; Wang Y; Liu D; Chen YM; Adjei AA; Midthun DE; Yang P
Lancet Oncol; 2019 Aug; 20(8):1098-1108. PubMed ID: 31255490
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer screening.
Tanoue LT; Tanner NT; Gould MK; Silvestri GA
Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
[TBL] [Abstract][Full Text] [Related]
16. Lung Cancer Screening at a Military Treatment Facility: A Retrospective Review.
White LJ; Kaur A; Lapel RT; E Boswell G; Luceri RE; Parrish JS; Seda G
Mil Med; 2020 Jun; 185(5-6):e864-e869. PubMed ID: 31925432
[TBL] [Abstract][Full Text] [Related]
17. Evaluating efficacy of current lung cancer screening guidelines.
Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
[TBL] [Abstract][Full Text] [Related]
18. Treatment capacity required for full-scale implementation of lung cancer screening in the United States.
Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
Cancer; 2019 Jun; 125(12):2039-2048. PubMed ID: 30811590
[TBL] [Abstract][Full Text] [Related]
19. Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations.
Richards TB; Doria-Rose VP; Soman A; Klabunde CN; Caraballo RS; Gray SC; Houston KA; White MC
Am J Prev Med; 2019 Jan; 56(1):66-73. PubMed ID: 30467092
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of cigarette and e-cigarette use among U.S. adults eligible for lung cancer screening based on updated USPSTF guidelines.
Heiden BT; Engelhardt KE; Cao C; Meyers BF; Puri V; Cao Y; Kozower BD
Cancer Epidemiol; 2022 Feb; 76():102079. PubMed ID: 34894590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]